Lilly in Advanced Talks to Acquire Kelonia for Over $2 Billion—Is a 39x P/E Still Too Rich? Life Science
Amazon Sees Billionaire Sell-Off of Over Half Their Stake, but This TSX Stock Becomes a New Favorite Energy, Technology
No Longer Afraid of Injections, Eli Lilly’s Oral Weight Loss Drug Foundayo Targets a Multibillion-Dollar Market Life Science
Netflix’s Disappointing Guidance Triggers Stock Plunge, Yet Analysts Shout ‘Buy the Dip’ Consumer Goods, Technology